The clinical course, biochemical markers, and clinical outcomes of COVID-19 positive patients from the third wave in Pakistan: A retrospective cohort study

Third wave of COVID-19 has affected several countries. Case fatality rates from first and second waves are expected to be surpassed by the current wave due to various variant transmissions. This study was aimed to compare and contrast the significant clinical markers between survivors and non-surviv...

Full description

Saved in:
Bibliographic Details
Published in:Annals of medicine and surgery 2022-05, Vol.77, p.103599-103599, Article 103599
Main Authors: Alam, Muhammad Tanveer, Mehdi, Asad, Timsaal, Yumna, Rehan, Muhammad, Kumar, Arjun, Shaikh, Imran Sarwar, Yasmin, Farah, Memon, Gul Muhammad, Ahmed, Nisar, Asghar, Muhammad Sohaib
Format: Article
Language:English
Subjects:
Cohort Study
COVID-19
Infection
Pandemic
SARS-CoV-2
Severity
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Third wave of COVID-19 has affected several countries. Case fatality rates from first and second waves are expected to be surpassed by the current wave due to various variant transmissions. This study was aimed to compare and contrast the significant clinical markers between survivors and non-survivors during the third wave of COVID-19 to assess severity and prognosis. It includes all the patients who were diagnosed with COVID-19 polymerase chain reaction (PCR) during the third wave, and were monitored for their disease course and outcomes. A total of 209 patients were included in the analysis via non-probability consecutive sampling method. The median age was higher in non-surviving patients (p = 0.010). Majority of deaths occurred in intensive care patients (p 
ISSN:2049-0801
2049-0801
DOI:10.1016/j.amsu.2022.103599